Pipeline Noticeocds-b5fd17-07dc3067-6795-4d2e-ac3b-8b9c5ebf2c16
NHS National Proprietary Pharmaceuticals - Eculizumab biosimilar
NHS National Proprietary Pharmaceuticals - Eculizumab biosimilar
Buyer
NHS England
Value
£60,000,000
Published
18 Aug 2022
Closes
18 Aug 2022
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Proprietary Pharmaceuticals - Eculizumab biosimilar
£60,000,000
NHS National Proprietary Pharmaceuticals - Eculizumab biosimilar
Delivery: England · United Kingdom, England, United Kingdom
Documents
Unlock document linkFuture opportunity notice on Contracts Finder
18 Aug 2022
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.